Ignite Creation Date:
2024-05-06 @ 2:50 AM
Last Modification Date:
2024-10-26 @ 11:24 AM
Study NCT ID:
NCT02132169
Status:
COMPLETED
Last Update Posted:
2017-09-11
First Post:
2014-04-29
Brief Title:
A Multi-Center Study Evaluating the Safety of AC-170 024
Sponsor:
Aciex Therapeutics Inc
Organization:
Aciex Therapeutics Inc
Study Overview
Official Title:
A Multi-Center Double-Masked Randomized Vehicle-Controlled Parallel-Group Study Evaluating the Safety of AC-170 024 Ophthalmic Solution Used Twice Daily in Healthy Adult Subjects and in Pediatric Subjects With a History or Family History of Atopic Disease Including Allergic Conjunctivitis
Status:
COMPLETED
Status Verified Date:
2017-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the safety of AC-170 024 used twice daily in Healthy Adult Subjects and in Pediatric subjects with a history or family history of atopic disease including allergic conjunctivitis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None